本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aura Biosciences, Inc.

6.27
-0.2700-4.13%
盘后:6.270.00000.00%19:44 EDT
成交量:166.32万
成交额:1,051.51万
市值:6.48亿
市盈率:-3.54
高:6.56
开:6.53
低:6.18
收:6.54
52周最高:9.54
52周最低:4.73
股本:1.03亿
流通股本:7,464.31万
量比:1.81
换手率:2.23%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
净资产收益率:-53.49%
总资产收益率:-31.24%
市净率:2.06
市盈率(LYR):-3.56

数据加载中...

2022/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

SEC问询函

CORRESP [Cover] - Correspondence